Notably, 17% of DLBCL cases exhibited mutations in ATM, while 11% displayed TP53 mutations, including hotspots in TP53 (p.Arg175His, COSV52661038, and p.Gly245Ser, COSV52661877). Here, TP53 is linked to diffuse large B-cell lymphoma.